Current Studies
Currently, about 30 own clinical studies are conducted at the NCRC – Neuroscience Clinical Research Center at the Charité - Universitätsmedizin Berlin on neurological and (neuro-) psychiatric diseases.
- studies on Multiple Sclerosis (MS)
- studies on Neuromyelitis Optica (NMO)
- studies on Stroke
- studies on Myasthenia Gravis
- studies on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- studies on Mild Cognitive Impairment (MCI) and Alzheimer's Disease
- studies on Brain Functions
- studies on Psychiatric Diseases
- studies on Parkinson Syndrome
- studies on Neuroprognostics
- studies on Neurological Sequelae and Neurotoxicity
The studies listed here represent only a selection of the many diagnostic and therapeutic studies offered at the NCRC. In addition to our own studies, we also take part in studies carried out by pharmaceutical companies.
- AON-S: Acute Optic Neuritis Study
- BERLimmun: Berlin Registry of Neuroimmunological Entities
- HOPE-MS: Clinical validity of an episodic self-measurement of motor function to assess disease progression in people with multiple sclerosis
- MSIM: Magnetic resonance imaging (MRI) in the characterization of cerebral lesions in inflammatory versus non-inflammatory CNS disorders and their association over the course of a clinical disease
- PARES: Patient-centered development of communication formats of scientific results to participants of clinical trials
- NEMOS: Database of the Neuromyelitis optica study group
- SecUse: Scientific utilization of data from the already completed studies CIS cohort, ViMS and NMO cohort
- MYA-IN-DEPTH: Myasthenia gravis - In depth-characterization of antibody-specific pathomechanisms at the neuromuscular junction and identification of novel autoantibodies
- MYASTHENIA Cohort: Myasthenia Gravis: diagnostic, prognostic, and therapy response markers
- RWE RavEcu: Treatment satisfaction of myasthenia patients under complement inhibitors in standard clinical care in Germany - a multicenter observational study
- Mya-Keto: Ketogenic diet as a complementary therapy for myasthenia gravis - a randomized controlled trial
- PROGNO-MG: Multicenter study to explore a biomarker (profile) for the future prediction of highly active disease progression in immunotherapy-naïve myasthenia patients
- MG thymectomy: Influence of thymectomy on the course of myasthenia gravis and the role of the surgical procedures